financetom
Business
financetom
/
Business
/
ING Comments on Euro, Poland's Zloty, Czech Republic's Koruna
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ING Comments on Euro, Poland's Zloty, Czech Republic's Koruna
Aug 29, 2025 3:53 AM

06:35 AM EDT, 08/29/2025 (MT Newswires) -- The European Central Bank's July minutes showed the Governing Council isn't as concerned about the euro's strength as some had speculated, but multiple members did point to downside risks to inflation and that, in ING's view, still suggests market pricing for year-end (-10bps) is too hawkish.

Anyway, given the silence of ECB doves of late and President Christine Lagarde reiterating that the ECB is in a good place with its current 2% rate, a dovish repricing doesn't seem to be a particularly imminent story, wrote the bank in a note.

Friday, investors will see the first prints of the eurozone's August inflation, with France, Spain, Italy and Germany releasing numbers. Expectations are for broadly unchanged year-on-year figures from July, resulting in a modestly higher eurozone-wide headline reading and a modestly lower core print -- to be released on Tuesday. The ECB's inflation expectations for July are also published on Friday.

All in all, ING doesn't think there will be much in the data to convince markets to materially reprice ECB rate expectations just yet. The French political earthquake is being endogenized and the bank doesn't think it will hurt the euro much unless snap elections become the baseline scenario.

EUR/USD remains cheap according to ING's short-term fair value model and it still favors a break above 1.170 in the next few days.

The bank sees any weakness in Poland's zloty (PLN) on Friday as an opportunity for new long positions ahead of next week's central bank meeting.

ING remains bullish on the Czech Republic's koruna (CZK) and EUR/CZK should return below 24.500.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved